ArticleJournal of gastrointestinal cancer2024
The Prediction of DLL4 as a Prognostic Biomarker in Patients with Gastric Cancer Using Anti-DLL4 Nanobody.
Reza Afzalipour et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it